We discovered that co-incubation of anlotinib and CQ resulted in further reduction of VEGFA levels in tumor supernatant when compared with anlotinib or CQ treatment alone (Fig. 4d) and further in vivo experiments demonstrated similar results (Fig. 6d, e). The gene discussed is VEGFA; the disease is neoplasm.